Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [<sup>68</sup>Ga]Ga-ABY-025 tracer.

Jussing, Emma; Ferrat, Mélodie; Moein, Mohammad M; Alfredéen, Henrik; Tegnebratt, Tetyana; Bratteby, Klas; Samén, Erik; Feldwisch, Joachim; Altena, Renske; Axelsson, Rimma; Tran, Thuy A

Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [⁶⁸Ga]Ga-ABY-025 tracer.

Jussing, Emma; Ferrat, Mélodie; Moein, Mohammad M; Alfredéen, Henrik; Tegnebratt, Tetyana; Bratteby, Klas; Samén, Erik; Feldwisch, Joachim; Altena, Renske; Axelsson, Rimma; Tran, Thuy A.

Afiliação

Jussing E; Department of Radiopharmacy, Karolinska University Hospital, 171 76, Stockholm, Sweden. emma.jussing@ki.se.
Ferrat M; Department of Oncology and Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden. emma.jussing@ki.se.
Moein MM; Department of Radiopharmacy, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Alfredéen H; Department of Oncology and Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
Tegnebratt T; Department of Radiopharmacy, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Bratteby K; Department of Oncology and Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
Samén E; Department of Radiopharmacy, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Feldwisch J; Department of Oncology and Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
Altena R; Department of Radiopharmacy, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Axelsson R; Department of Radiopharmacy, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Tran TA; Department of Oncology and Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.